Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
2023 · Materials Today Bio · 34 citations
https://doi.org/10.1016/j.mtbio.2023.100675
X
Xin-Li Han
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
177
Citations
7
h-index
7
i10-index
Xin-Li Han is an academic researcher from Chinese PLA General Hospital. The author has contributed to research in topics: Crystallization and Solubility Studies & X-ray Diffraction in Crystallography & Nanoplatforms for cancer theranostics. The author has an h-index of 7, co-authored 25 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat